Recent developments in drug discovery against the protozoal parasites Cryptosporidium and Toxoplasma
ORCID
Kirkwood M. Land: 0000-0001-5951-9630
Document Type
Article
Publication Title
Bioorganic & Medicinal Chemistry Letters
Department
Biological Sciences
ISSN
0960-894X
Volume
27
Issue
7
DOI
10.1016/j.bmcl.2017.01.046
First Page
1491
Last Page
1501
Publication Date
4-1-2017
Abstract
Apicomplexan parasites cause some of the most devastating human diseases, including malaria, toxoplasmosis, and cryptosporidiosis. New drug discovery is imperative in light of increased resistance. In this digest article, we briefly explore some of the recent and promising developments in new drug discovery against two apicomplexan parasites, Cryptosporidium and Toxoplasma.
Recommended Citation
Chellan, P.,
Sadler, P. J.,
&
Land, K. M.
(2017).
Recent developments in drug discovery against the protozoal parasites Cryptosporidium and Toxoplasma.
Bioorganic & Medicinal Chemistry Letters, 27(7), 1491–1501.
DOI: 10.1016/j.bmcl.2017.01.046
https://scholarlycommons.pacific.edu/cop-facarticles/778
